Technical Entity Trends: Artificial Intelligence Marks A New Drug Lifecycle June2019Technical Entity TrendsExpedito SegoviaA wave of change is spreading across many industries due to technological advances enabled by artificial intelligence (AI) and automation. The pharmaceutical industry is no exception and is harnessing AI tools for new drug discovery and development...
A Chat with Twist Bioscience's Emily Leproust on DNA Synthesis May 30, 2019Twist Bioscience CEO, cofounder, and director Emily Leproust discusses the company's work and the promising future of synthetic biology.
Is Synthetic Biology Having a Moment? February 15, 2019Suddenly, synthetic biology is being discussed a lot beyond the walls of academia and the pages of scientific journals. Today, it abounds in the mainstream press.
Shellfish Show Wide-Ranging Potential for Medical Research January 30, 2019Understanding the bivalve genome and the mechanisms of how they fight disease could lead to new drugs, therapies, and novel biomaterials.
Ryan C. Snyder, Bucknell University: The Future of Chemical Engineering September 8, 2018Hear Ryan's perspective on what advances he thinks chemical engineering has ahead of it.
Robert Steininger, Surface Oncology Inc.: The Future of Chemical Engineering August 28, 2018A look at the future of chemical engineering from the perspective of pharmaceutical manufacturing.
CEP: News Update June2018News UpdateDragonflies Inspire a New Way To Create and Dry Aerogels When a dragonfly emerges from its underwater larval stage and stretches out its wings for the first time, those wings are as soft as jelly. But after a mere hour or so, they are solid and...
Broad-Spectrum Antiviral Shown to Inhibit Coronaviruses March 7, 2018A new experimental broad-spectrum antiviral drug could be used to combat the type of virus that causes the common cold and pneumonia, as well as more lethal viruses such as SARS and MERS.
Printing Tech Recreates Biological Structures with Cells and Molecules March 6, 2018Technique allows for the observation of how cells and molecules react in their natural environment, presenting possibilities for biomedical and pharmaceutical applications.
Biological Engineers Have Challenge in Antibiotic Resistance February 28, 2018A new report released by the European Centre for Disease Prevention and control (ECDC) emphasizes that antimicrobial resistance remains one of the greatest public health threats today.
Nanoparticle Designed to Destroy Harmful Viruses January 4, 2018An international team of researchers has created new antiviral nanoparticles that show potential for outperforming current antiviral drugs.
New Structural Knowledge of Key Protein May Improve Drug Design January 3, 2018New imagine of a key protein's signaling mechanism provides insights for better pharmaceuticals.
Researchers Find Clues to Zika's Rise in Severity October 9, 2017Researchers at the University of Nebraska-Lincoln have uncovered clues about how the Zika virus became much more dangerous in recent years.
Genetic Variation Identifies High-Risk Flu Patients July 18, 2017Researchers have identified an inherited genetic variation that they believe helps identify those at the highest risk for potentially fatal influenza infections.
Technique Identifies Influenza Mutations' Pandemic Potential July 7, 2017A new technique labels gene segments to help understand how the virus enters a cell and establishes co-infections.
BioTM Articles Topping Altmetrics Charts June 27, 2017In its first year, BioTM is already topping the charts, with top ratings for viewing, sharing, and discussion of articles.
Technical Entity Trends: A World Transitioning to Translational Medicine June 2, 2017The failure rate for new drugs and therapies under development exceeds 95%.
Weakness Identified in Zika Virus Blocks Propagation May 17, 2017Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have published findings that may represent a first step towards a drug treatment for Zika infections.
Technical Entity Trends: A World Transitioning to Translational Medicine May2017Technical Entity TrendsGabriel Levesque-TremblayThe failure rate for new drugs and therapies under development exceeds 95%. For the other 5%, it takes at least 14 years and more than $1 billion to develop a successful candidate into a product that can be delivered to patients. The field of...
Could Caribbean Snail Battle Opioid Addiction? February 27, 2017A compound found in a snail's venom yields pain-fighting effects in testing, presenting a possible opioid alternative.
Fruit Fly Finding Could Fight Human Cancers January 26, 2017Researchers at Indiana University Bloomington have discovered that a molecule related to some forms of cancer and neurodegenerative disorders is also present in developing Drosophila
Little Bio-Machinery to Solve Grand Challenges January 3, 2017As we approach ICBE 2017, which begins this weekend in San Diego, we look back at some of the exciting research that figured among 2016's highlights and look forward to the new developments to be unveiled at ICBE 2017.
Study Points to Therapeutic Cancer Vaccine December 30, 2016Researchers at the University of Michigan have had a significant breakthrough in creating a customized therapeutic vaccine for treating colon and melanoma cancer tumors in mice.
Latest Issue of of BioTM Devoted to Smart and Precision Medications December 27, 2016This special issue focuses on smart and precision medications, presenting novel work aimed at a wide range of medical applications, from diabetes treatments, cancer therapy, tissue engineering, drug delivery, and more.
Anti-Apoptotic Proteins Undervalued in Search for Cancer Therapies December 12, 2016Researchers at the University of California, Riverside, recently published work that suggests that the usefulness of studying pro- and anti-apoptotic proteins in a search for cancer
Competition to Reward Chemical Engineers for Underwater Chemical Discovery October 5, 2016By Dr. Jyotika Virmani
Synthetic DNA Could Redefine Drug Design September 15, 2016A startup in southern California is designing microbes that extend DNA beyond the natural A, T, G, and C components to include X and Y.
Possible Path to Vaccine for Flesh-Eating Bacteria September 7, 2016It sounds like something straight out of a science fiction movie: bacteria that feeds on human flesh.
First Issue of Bioengineering & Translational Medicine Now Available Online July 25, 2016AIChE and the Society for Biological Engineering (SBE) have launched with publishing partner Wiley the new open-access journal Bioengineering & Translational Medicine, whose
Major Public Database to Fuel Personalized Medicine July 8, 2016The U.S. government announced this week that it is putting aside $55 million to create a public database with health information on about one million volunteers.